Mounjaro Side Effects: What to Expect, and When to Act

Step 1: What most people notice in the first few weeks

The side-effect story for tirzepatide is front-loaded. Most people who experience anything at all notice it earliest, in the first days after starting, or after a dose step upward. Nausea is the one that comes up most, followed by loose stools, constipation, indigestion, reflux, and burping. Fatigue, headache and dizziness also appear in the data but tend to be milder and shorter-lived. For a detailed clinical breakdown of each individual effect, the NHS tirzepatide medicines page categorises them by frequency using standard trial terminology.

One misconception worth addressing: many people assume the nausea means the medicine is not working, or that they should stop. That is rarely the case. The starter dose exists specifically to let the body adjust; it is a tolerability measure, not a therapeutic target. If you want a fuller picture before you begin, our page on what side effects to expect when taking Mounjaro walks through each one in plain language. That said, if vomiting is severe enough that you cannot keep fluids down, that warrants a call to your care team, it moves from a nuisance to a clinical consideration at that point.

Injection-site reactions (redness, itching, a small lump) are also reported, more so by people newer to self-injection. Rotating sites between the abdomen, thigh and upper arm on each weekly dose reduces this. Our Mounjaro overview covers storage and practical injection guidance in more detail.

Step 2: Side effects that can develop over a longer period

Some effects emerge more gradually and are worth understanding before you begin. Gallbladder problems (including gallstones) are more common during significant weight loss generally, and GLP-1 medicines are no exception. Symptoms include sudden pain in the upper right abdomen, pain spreading to the shoulder, or fever alongside nausea. These should not be self-managed.

There is also evidence of slowed gastric emptying becoming a sustained feature for some people rather than an early-weeks phenomenon. This can affect how quickly other oral medicines and food are absorbed, a practical consideration for anyone on anticoagulants, thyroid medicines or hormonal contraception. If you want more context on what the longer arc of treatment can look like, the long-term side effects of Mounjaro page covers this in depth.

Hair thinning, sometimes called telogen effluvium, is occasionally reported during rapid weight loss. It is a response to the physiological stress of losing weight quickly rather than a direct drug effect, and it typically reverses. Acknowledging it here matters because it surprises people who were not told to expect it. The risks of Mounjaro page goes further into the evidence base behind these less-discussed effects.

Step 3: Symptoms that need urgent medical attention

A small number of side effects require prompt action rather than watchful waiting. Knowing them in advance is part of taking any prescription medicine responsibly.

Acute pancreatitis is the one regulators have specifically highlighted. In January 2026, the MHRA issued a Drug Safety Update for GLP-1 medicines (including tirzepatide) confirming that acute pancreatitis is a known, infrequent but potentially serious risk. The presentation to watch for: severe, persistent pain in the abdomen that radiates toward the back, with or without vomiting. Stop treatment and seek emergency medical help immediately if this occurs.

Other symptoms that warrant urgent contact with a doctor: signs of a serious allergic reaction (swelling of the face, lips, tongue or throat; difficulty breathing; a rapid rash); symptoms of severe dehydration caused by persistent vomiting or diarrhoea (dizziness on standing, very dark urine, unable to keep fluids down); and, for anyone who also has diabetes, any signs of low blood sugar when taking Mounjaro alongside insulin or a sulphonylurea.

If low mood, anxiety or thoughts of self-harm emerge during treatment, speak to your GP or call 111. Any suspected side effect (common or unexpected) can and should be reported to the MHRA via the Yellow Card scheme. That reporting data actively shapes future safety guidance.

For a broader picture of how tirzepatide's side-effect profile compares as a GLP-1 receptor agonist, the side effects of tirzepatide page sits alongside this one.

Practical steps that reduce side-effect burden

Evidence from the SURMOUNT trials and clinical practice consistently points to the same set of behaviours reducing GI discomfort. Eating smaller portions slowly, avoiding very fatty or spicy food in the early weeks, and staying well hydrated all help. The NHS tirzepatide guidance includes practical advice on managing nausea that is worth reading alongside the patient information leaflet in your pen box.

At nume, our prescribers discuss your individual side-effect risk as part of the clinical review before treatment begins, not as a formality, but because the right preparation genuinely changes how people experience the first few weeks. It is also worth knowing that when the time comes to stop, our page on what side effects can occur when coming off Mounjaro explains what to expect during that transition. If you are weighing up whether Mounjaro is the right option for you, checking your eligibility through a free consultation is the starting point, our prescribers go through suitability, contraindications and what to expect before anything is dispensed.